Shuya Feng

机构：Central South University, Third Xiangya Hospital

发表论文 19 篇 · 总被引 593 次 · h-index 8

代表论文

• MicroRNA-101 Inhibited Postinfarct Cardiac Fibrosis and Improved Left Ventricular Compliance via the FBJ Osteosarcoma Oncogene/Transforming Growth Factor-β1 Pathway (2012 · Circulation · 被引 320)
• Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGFβ1 expression and activation of p38‐MAPK and ERK1/2 (2010 · British Journal of Pharmacology · 被引 107)
• DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax (2022 · Theranostics · 被引 80)
• Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia (2024 · Experimental Hematology and Oncology · 被引 34)
• The Transcriptional Coactivator, ALL1‐Fused Gene From Chromosome 9, Simultaneously Sustains Hypoxia Tolerance and Metabolic Advantages in Liver Cancer (2021 · Hepatology · 被引 20)
• Lipase-triggered drug release from BCL2 inhibitor ABT-199-loaded nanoparticles to elevate anti-leukemic activity through enhanced drug targeting on the mitochondrial membrane (2022 · Acta Biomaterialia · 被引 11)